Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

BioDelivery Sciences International Inc

+ Add to Watchlist

BDSI:US

7.8600 USD 0.2200 2.72%

As of 17:20:00 ET on 06/02/2015.

Snapshot for BioDelivery Sciences International Inc (BDSI)

Open: 8.0500 Day's Range: 7.7900 - 8.1700 Volume: 6,911,245
Previous Close: 8.0800 52wk Range: 7.2800 - 18.4800 1-Yr Rtn: -21.08%

Stock Chart for BDSI

No chart data available.
  • BDSI:US 7.8600
  • 1D
  • 1M
  • 1Y
8.0800
Interactive BDSI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BDSI

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.1700
Est. EPS (USD) (12/2015) -0.2990
Est. PEG Ratio -
Market Cap (M USD) 411.89
Shares Outstanding (M) 52.40
30 Day Average Volume 1,134,730
Price/Book (mrq) 8.2576
Price/Sale (ttm) 12.5951
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BDSI

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BDSI

BioDelivery Sciences International, Inc. is a development-stage biotechnology company that is developing and seeking to commercialize a drug delivery technology. The Company's technology is designed for a broad base of pharmaceuticals, vaccines, and over-the-counter drugs. Biodelivery's technology encapsulates the selected drug in a cochleate cylinder.

Francis E O'Donnell JrChairmanMark A SirgoPresident/CEO
Ernie R De PaolantonioCFO/Secretary/TreasurerAndrew L FinnExec VP:Product Development
More Company Profile & Key Executives for BDSI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil